Ass.-Prof. Priv.-Doz. Dr. Doris E. Braun
CD Laboratory for Advanced Crystal Engineering Strategies in Drug Development

Pharmaceutical Technology – Departement of Pharmacy
Innrain 52c, 6020 Innsbruck
+43 (512) 507 58653

This CD Laboratory aims to research critical material properties of pharmaceutical excipients and active pharmaceutical ingredients that are crucial for the production, quality and safety of high-quality drugs. Optimising these properties makes it possible to accelerate manufacturing processes and ultimately reduce the costs of essential drug products.
Most active pharmaceutical ingredients consist of small molecules, which are usually processed into tablets in crystalline for reasons of chemical stability. The increasing complexity of modern drugs often leads to a deterioration in water solubility. However, material science approaches such as ‘crystal engineering’ enable the production of different solid forms with different pharmaceutically relevant properties. The aim is to find the optimal form(s) of biologically active molecules in terms of stability, solubility and processability in order to develop them into high quality and marketable drugs.
Virtual screening methods can significantly accelerate the experimental effort and the discovery of new solid forms. Although ‘Crystal Structure Prediction (CSP)’ is considered the gold standard for predicting crystal structures, it is very time-consuming and computationally expensive, especially for multi-component systems such as cocrystals. Simplified approaches are therefore often used, such the analysis of molecular complementarity, hydrogen bonding or the calculation of electrostatic potentials. However, these methods have limited predictive power. The aim of this research focus is to combine these approaches in a targeted manner and to further develop virtual screening methods through an iterative process of in silico prediction, data mining and experimentation.

Integration of virtual cocrystal screening methods into experimental solid mould screening and the determination of physicochemical properties.
Metastable solid forms play a crucial role in improving the solubility of poorly water soluble drugs. Amorphous solid dispersions have been established as a promising method to stabilise amorphous forms. Embedding in a matrix and combination with specially selected additives prevents crystallisation. In addition, particle coatings or encapsulations can be used to protect the surfaces of crystalline metastable solid forms and prevent phase transformations. In this way, metastable solid forms can be effectively used in pharmaceuticals.
The mechanical properties of solid forms are critical for the processing and formulation of active ingredients. Deeper insight into the underlying molecular interactions allows a better understanding of the behaviour of the solid form under pressure, during grinding or compaction. The aim is to investigate the relationship between mechanical properties, which are determined by compaction analyses, and structural characteristics, with the ultimate aim of being able to predict important mechanical properties from structural data.